Status:
COMPLETED
Evaluation of Prognostic Factors for Tubo-ovarian Cancer in France
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Ovarian Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
Evaluation of the following prognostic factors in France, based on national quotation data: volume per center, patient age, geographic distance from a clinical center, delay for chemotherapy,Upfront s...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- \- Diagnosic of Ovarian or Tubal Cancer C56 et C570
- +/-
- Carcinose péritonéale C786
- Tumueur maligne secondaire de la plèvre C782,
- Tumueur maligne secondaire des ganglions C770 à C779,
- Tumueur maligne secondaire du foie C787,
- Tumueur maligne secondaire du péritoine C786
- Exclusion criteria:
- autres causes de :
- Carcinose péritonéale C786
- Tumueur maligne secondaire de la plèvre C782,
- Tumueur maligne secondaire des ganglions C770 à C779,
- Tumueur maligne secondaire du foie C787,
- Tumueur maligne secondaire du péritoine C786
Exclusion
Key Trial Info
Start Date :
January 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2021
Estimated Enrollment :
22500 Patients enrolled
Trial Details
Trial ID
NCT05204342
Start Date
January 1 2012
End Date
December 30 2021
Last Update
January 24 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uhmontpellier
Montpellier, France, 34295